Replies to post #226841 on Biotech Values

[DewDiligence]

PFE/MYL—Viatris* merger now expected to close in 2H20 (rather than 1H20):

https://www.businesswire.com/news/home/20200326005190/en/Mylan-Pfizer-Provide-Update-Proposed-Combination-Mylan

*MYL + PFE’s Upjohn unit for off-patent drugs.